Masaru Matsuda sold $584K of Arcutis Biotherapeutics (ARQT)

Executed Sep 4 2025, disclosed Sep 8 2025, 4 days later.

Value, as filed

$584K

36,130 sh × $16.16

Executed

Sep 4 2025

the trade date, as filed

Disclosed

Sep 8 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Masaru Matsuda See Remarks profile →

Masaru Matsuda (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.0M of ARQT (40,638 sh across 4 lots, as filed), executed Feb 2.

The name

ARQT

Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Masaru Matsuda in ARQT

ARQTSALE Arcutis Biotherapeutics, Inc. $250K
9,989 sh × $25.03
Exec Sep 8
Filed Sep 10 · 7:24 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $172K
7,372 sh × $23.27
Exec May 4
Filed May 6 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $165K
6,553 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $1.0M
40,638 sh across 4 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $177K
7,165 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $106K
8,338 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET